FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
Bristol-Myers Squibb
Bristol-Myers Squibb

Bristol-Myers Squibb

BMYHealth care

Stock · Data from SEC EDGAR 13F · Held by 14 of 87 tracked investors

$61.48
▼ 2.41%
Famous investorshold 14buying 1selling 0
Price (USD)
$61.48
Market cap
$126B
P/E ratio
13.5
Tracked investors holding
14 of 87
Next earnings
29 Oct 2026

Bristol-Myers Squibb at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
75out of 100
  • Valuation88
  • Growth43
  • Profitability87
  • Quality95
  • Debt60
  • Stability79
In its favour
  • Out of 100 USD of revenue, 19 USD is left as net profit.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202630 Jul 20262.041.59+28.3%
Mar 202630 Apr 20261.581.44+9.7%
Dec 20255 Feb 20261.261.15+9.6%
Sep 202530 Oct 20251.631.48+10.1%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+2.90%
1M
-0.03%
3M
-0.98%
YTD
+15.00%
1Y
+40.27%
3Y
+20.50%
5Y
+5.27%
Forward P/E
9.3
Dividend yield
4%
52-week low
$42.52
52-week high
$68.64

Chart BMY

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

14
RP
Richard Pzena
Pzena Investment Management
2.88%$979,945,875▼ -0.5%
BM
Bill Miller
Miller Value Partners
0.95%$4,004,590unchanged
CA
Cliff Asness
AQR Capital Management
0.55%$1,576,338,331▼ -7.7%
JR
John Rogers
Ariel Investments
0.4%$40,128,297▼ -3.5%
Ns
Norský státní fond
Norges Bank
0.21%$2,124,256,834New position
Čn
Česká národní banka
Česká národní banka
0.19%$36,623,870▲ +1%
Šn
Švýcarská národní banka
Swiss National Bank
0.17%$331,822,056▼ -3.6%
TB
Tweedy Browne
Tweedy, Browne Company
0.16%$2,164,783▲ +43.6%
JG
Joel Greenblatt
Gotham Asset Management
0.12%$51,452,874▲ +3.6%
GI
Generali Investments CEE
Generali Investments CEE
0.05%$1,031,398unchanged
MG
Mario Gabelli
GAMCO Investors
0.04%$4,763,503▼ -5%
IE
Israel Englander
Millennium Management
0.02%$43,363,429▼ -88.5%
KG
Ken Griffin
Citadel Advisors
0.01%$90,597,597▲ +5.2%
KF
Ken Fisher
Fisher Investments
0%$9,991,553▼ -14.9%

Frequently asked questions

How much is Bristol-Myers Squibb (BMY) stock?

Bristol-Myers Squibb shares trade at $61.48, -2.41% over the last trading day. The price is delayed.

What is the market cap of Bristol-Myers Squibb?

The market cap of Bristol-Myers Squibb is about $126B and its price-to-earnings ratio (P/E) is 13.5.

Does Bristol-Myers Squibb pay a dividend?

The dividend yield of Bristol-Myers Squibb is 4% a year. The yield can change with the company's decisions.

How has Bristol-Myers Squibb stock performed over the last year?

The Bristol-Myers Squibb share price changed by +40.27% over 12 months and by +5.27% over 5 years.

Which big investors hold Bristol-Myers Squibb?

According to the latest 13F filings, 14 of 87 tracked investors hold Bristol-Myers Squibb, for example Richard Pzena, Bill Miller, Cliff Asness.

When will Bristol-Myers Squibb report its next results?

The next earnings report of Bristol-Myers Squibb is expected on 29 Oct 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
  • ✓It earns 47 USD a year on every 100 USD of invested capital (ROE).
  • ✓It pays a 4% dividend, which takes 55% of earnings.
  • ✓The stock is cheaper: you pay 13.5 USD for 1 USD of annual earnings.
  • What to watch
    • !Revenue grew only 1.4% a year over 3 years.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Fairly cheap

    For 1 USD of annual earnings you pay 13.5 USD. Based on next year's estimates 9.3 USD.

    P/E
    13.5×
    P/S
    2.6×
    EV/EBITDA
    8.4×

    Is the company growing?

    Flat
    22
    23
    24
    25

    Revenue over 3 years grew 1.4% a year. Last year 5.7%.

    Does it make money?

    Good
    • Cost of sales 29
    • Research 20.6
    • Operations and selling 22.0
    • Taxes and other 13.8
    • Net profit 14.6

    Out of 100 USD of revenue, 14.6 USD is left as net profit.

    Is it financially healthy?

    Mostly
    Cash
    11.1B USD
    Debt
    45.1B USD
    Free CF
    8.1B USD

    It could repay its net debt from free cash flow in 4.2 years.

    Does it pay a dividend?

    Pays
    Yield
    4.00%
    Of earnings
    55%

    Over a year you receive roughly 4.00% of the price per share. The payout is manageable for the company. It has raised the dividend for 4 years in a row.

    What do analysts expect?

    Buy
    Average target
    65.42 USD
    Vs price
    +6%

    24 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    14 of 87

    Among the tracked investors, Richard Pzena, Bill Miller, Cliff Asness and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    13.5×
    Forward P/E
    9.3×
    P/B
    5.6×
    P/S
    2.6×
    PEG
    17.54
    EV/EBITDA
    8.4×
    Gross margin
    71.7%
    Operating margin
    34.4%
    Net margin
    18.9%
    ROE
    46.6%
    ROA
    10.7%
    Debt / equity
    2.0×
    Current ratio
    1.5×
    Revenue growth
    5.7%
    Earnings growth
    153.1%
    Beta
    0.18
    Dividend
    4.00%
    Payout ratio
    55%